Elizabeth Glaser Pediatric AIDS Foundation partners with the American Cancer Society in Swaziland. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a… read more.
A ground-breaking international collaborative survey, published today in Annals of Oncology, shows that more than half of the world’s population live in countries where regulations that aim to… read more.
Heinrich Schima, Vienna, Austria – In the last decades, ventricular-assist devices (VADs) – artificial hearts – have gone from pioneering experiments to offering a real alternative to heart… read more.
by Jamie Von Roenn, MD, and Charles von Gunten, MD, PhD – The call to integrate palliative care practices and principles into comprehensive cancer care, not as something… read more.
Advocates and pain management groups aired concerns recently over a citizen petition to change opioid labeling during the first of a 2-day FDA hearing.
Safe and effective – Researchers have found that tumour “separation surgery” followed by high-dose hypofractionated stereotactic radiosurgery (SRS) or high-dose single-fraction SRS is safe and effective in controlling… read more.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
The combination also appears to be cost effective. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with… read more.
by Christine Clark – Changes in the diagnosis and treatment of cancer form the basis for future developments. There have been many revolutions in medical science over the… read more.
by Thomas R. Collins – A living donor liver transplant can be a safe and effective first-line treatment for very young children with biliary atresia,
by Dr Sunil Upadhyay – There is clear evidence that the USA spends twice as much as any other country per GDP on cancer treatment but, except for… read more.
by Dr Sunil Upadhyay – Since the publication of the iPASS trial data, gefitinib has become the treatment of choice in EGFR mutation positive tumours. However, almost all… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
